Chris Degnan
Director Financiero/CFO en GALERA THERAPEUTICS, INC. .
Fortuna: 2 070 $ al 30/04/2024
Cargos activos de Chris Degnan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GALERA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | - |
Director Financiero/CFO | 21/10/2019 | - | |
Contacto de Relaciones con Inversores | 21/10/2019 | - | |
Secretario Corporativo | 21/10/2019 | - |
Historial de carrera de Chris Degnan
Antiguos cargos conocidos de Chris Degnan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/03/2018 | 07/10/2019 |
Director Financiero/CFO | 01/03/2018 | 07/10/2019 | |
ENDO INTERNATIONAL PLC | Director Financiero/CFO | 01/11/2014 | 01/03/2018 |
ASTRAZENECA PLC | Director Financiero/CFO | 01/01/2004 | 01/11/2014 |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director Financiero/CFO | - | - |
Formación de Chris Degnan.
University of Notre Dame | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Irlanda | 2 |
Reino Unido | 2 |
Operativa
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
VERRICA PHARMACEUTICALS INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
GALERA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Degnan
- Experiencia